Astrana Health, Inc.
Astrana Health, Inc. (ASTH) Stock Overview
Explore Astrana Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.2B
P/E Ratio
32.30
EPS (TTM)
$0.73
ROE
0.07%
ASTH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Astrana Health, Inc. (ASTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $47.47.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.30 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.